Unbound MEDLINE

The effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] Journal article

 
TitleThe effect of chronic hepatitis C virus infection on bone disease in postmenopausal women.
Author(s)Nanda KS, Ryan EJ, Murray BF, Brady JJ, McKenna MJ, Nolan N, O'Farrelly C, Hegarty JE 
InstitutionNational Liver Transplant Unit, St. Vincent's University Hospital, Dublin, Ireland.
SourceClin Gastroenterol Hepatol 2009 Jan 24.
AbstractBACKGROUND & AIMS:: Limited data are available on the contribution of chronic hepatitis C virus (HCV) infection to the development of bone disease in postmenopausal women. We studied whether women who acquired HCV infection through administration of HCV genotype 1b-contaminated anti-D immunoglobulin from a single source had decreased bone mineral density (BMD) or altered levels of bone formation and resorption markers, compared to women who spontaneously resolved infection or age-matched healthy controls.
METHODS:: From a cohort of postmenopausal Irish women, we compared BMD, determined by dual-energy X-ray absorptiometry and a panel of bone turnover markers (BTM), in 20 women chronically infected with HCV (PCR+), 21 women who had spontaneously resolved infection (PCR-) and 23 age-matched healthy controls.
RESULTS:: Levels of BTMs and BMD were similar in PCR+ and PCR- women and healthy age-matched controls. However, there was an increased frequency of fractures in PCR+ (n=6) compared with PCR- women (n=0), (p=0.007). PCR+ women with fractures were postmenopausal for longer (median 15.5 [range 5-20] vs 4.5 [1-20] years in PCR+ women without fractures; p=0.033), had lower BMD at the hip (0.79 [0.77-0.9] vs 0.96 [0.81-1.10] g/cm(2); p=0.007) and had a lower body mass index 23.7 (21.2-28.5) vs. 25.6 (22.1-36.6) kg/m2, p=0.035). There was no difference in liver disease severity or bone turnover markers in PCR+ women with or without fractures.
CONCLUSIONS:: Chronic HCV infection did not lead to discernable metabolic bone disease in postmenopausal women, but may be a risk factor for bone fractures, so preventive measures should be introduced.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19558999
  
Advertise on this site.